Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1036027-52-7

Post Buying Request

1036027-52-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1036027-52-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1036027-52-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,6,0,2 and 7 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1036027-52:
(9*1)+(8*0)+(7*3)+(6*6)+(5*0)+(4*2)+(3*7)+(2*5)+(1*2)=107
107 % 10 = 7
So 1036027-52-7 is a valid CAS Registry Number.

1036027-52-7 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Aldrich

  • (ADE000615)  5-(Trifluoromethyl)-3-((trimethylsilyl)ethynyl)pyridin-2-amine  AldrichCPR

  • 1036027-52-7

  • ADE000615-1G

  • 7,411.95CNY

  • Detail

1036027-52-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(trifluoromethyl)-3-(2-trimethylsilylethynyl)pyridin-2-amine

1.2 Other means of identification

Product number -
Other names 5-trifluoromethyl-3-trimethylsilanylethynyl-pyridin-2-ylamine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1036027-52-7 SDS

1036027-52-7Relevant articles and documents

OXADIAZINE COMPOUNDS AND METHODS OF USE THEREOF

-

, (2017/03/14)

The present disclosure relates to oxadiazine compounds, pharmaceutical compositions comprising an effective amount of an oxadiazine compound and methods for using an oxadiazine compound in the treatment of a neurodegenerative disease, comprising administering to a subject in need thereof an effective amount of an oxadiazine compound.

NEW IMIDAZOLONE DERIVATIVES, PREPARATION THEREOF AS DRUGS, PHARMACEUTICAL COMPOSITIONS, AND USE THEREOF AS PROTEIN KINASE INHIBITORS, IN PARTICULAR CDC7

-

Page/Page column 42, (2009/10/17)

The present invention relates to imidazolone derivatives of formula (I) to methods of preparing such derivatives, intermediates thereto, pharmaceutical compositions comprising such derivatives, and methods of inhibiting protein kinase, and methods of treatment comprising administration of such derivatives.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1036027-52-7